MeiraGTx Holdings plc Finance Lease, Right-of-Use Asset, Amortization
MeiraGTx Holdings plc (MGTX) reported Finance Lease, Right-of-Use Asset, Amortization of $312.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-13
- MeiraGTx Holdings plc finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $312.00K, a 2.30% increase year-over-year.
- MeiraGTx Holdings plc finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $308.00K, a 123.19% increase year-over-year.
- MeiraGTx Holdings plc finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $315.00K, a 55.17% increase year-over-year.
- MeiraGTx Holdings plc finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $304.00K, a 39.45% increase year-over-year.
- MeiraGTx Holdings plc finance lease, right-of-use asset, amortization for fiscal 2025 was $1.21M, a 22.94% increase from fiscal 2024.
- MeiraGTx Holdings plc finance lease, right-of-use asset, amortization for fiscal 2024 was $981.00K, a 12.72% decline from fiscal 2023.
- MeiraGTx Holdings plc finance lease, right-of-use asset, amortization for fiscal 2023 was $1.12M, a 1.90% increase from fiscal 2022.
- MeiraGTx Holdings plc finance lease, right-of-use asset, amortization for fiscal 2022 was $1.10M, a 10.11% decline from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 3 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 6 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 9 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 12 month | Finance Lease, Right-of-Use Asset, Amortization 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $312.00K 10-Q · filed 2026-08-13 | $620.00K 10-Q · filed 2026-08-13 | $935.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.24M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $308.00K 10-Q · filed 2026-05-14 | $623.00K derived: sum of 2 quarters · filed 2026-05-14 | $927.00K derived: sum of 3 quarters · filed 2026-05-14 | $1.23M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $315.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $619.00K derived: sum of 2 quarters · filed 2026-03-30 | $924.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.21M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $304.00K 10-Q · filed 2025-11-13 | $609.00K derived: sum of 2 quarters · filed 2026-08-13 | $891.00K 10-Q · filed 2025-11-13 | $950.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $305.00K 10-Q · filed 2026-08-13 | $588.00K 10-Q · filed 2026-08-13 | $646.00K derived: sum of 3 quarters · filed 2026-08-13 | $864.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $138.00K 10-Q · filed 2026-05-14 | $341.00K derived: sum of 2 quarters · filed 2026-05-14 | $559.00K derived: sum of 3 quarters · filed 2026-05-14 | $840.00K derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $421.00K derived: sum of 2 quarters · filed 2026-03-30 | $702.00K derived: sum of 3 quarters · filed 2026-03-30 | $981.00K 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $218.00K 10-Q · filed 2025-11-13 | $499.00K derived: sum of 2 quarters · filed 2025-11-13 | $778.00K 10-Q · filed 2025-11-13 | $1.07M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $281.00K 10-Q · filed 2025-08-14 | $560.00K 10-Q · filed 2025-08-14 | $848.00K derived: sum of 3 quarters · filed 2025-08-14 | $1.12M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $281.00K 10-Q · filed 2025-05-13 | $567.00K derived: sum of 2 quarters · filed 2025-05-13 | $841.00K derived: sum of 3 quarters · filed 2025-05-13 | $1.12M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $286.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $560.00K derived: sum of 2 quarters · filed 2025-03-13 | $842.00K derived: sum of 3 quarters · filed 2025-03-13 | $1.12M 10-K · filed 2025-03-13 | ||||
| 2023-09-30 | $274.00K 10-Q · filed 2024-11-13 | $556.00K derived: sum of 2 quarters · filed 2024-11-13 | $838.00K 10-Q · filed 2024-11-13 | $1.11M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $282.00K 10-Q · filed 2024-08-12 | $563.00K 10-Q · filed 2024-08-12 | $841.00K derived: sum of 3 quarters · filed 2024-08-12 | $1.10M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $281.00K 10-Q · filed 2024-05-09 | $559.00K derived: sum of 2 quarters · filed 2024-05-09 | $816.00K derived: sum of 3 quarters · filed 2024-05-09 | $1.09M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $278.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $535.00K derived: sum of 2 quarters · filed 2024-03-15 | $810.00K derived: sum of 3 quarters · filed 2024-03-15 | $1.10M 10-K · filed 2024-03-15 | ||||
| 2022-09-30 | $257.00K 10-Q · filed 2023-11-14 | $532.00K derived: sum of 2 quarters · filed 2023-11-14 | $825.00K 10-Q · filed 2023-11-14 | $1.13M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $275.00K 10-Q · filed 2023-08-10 | $568.00K 10-Q · filed 2023-08-10 | $869.00K derived: sum of 3 quarters · filed 2023-08-10 | $1.17M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $294.00K 10-Q · filed 2023-05-11 | $594.00K derived: sum of 2 quarters · filed 2023-05-11 | $899.00K derived: sum of 3 quarters · filed 2023-05-11 | $1.21M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $605.00K derived: sum of 2 quarters · filed 2023-03-14 | $918.00K derived: sum of 3 quarters · filed 2023-03-14 | $1.23M 10-K · filed 2023-03-14 | ||||
| 2021-09-30 | $305.00K 10-Q · filed 2022-11-10 | $618.00K derived: sum of 2 quarters · filed 2022-11-10 | $927.00K 10-Q · filed 2022-11-10 | $1.22M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $313.00K 10-Q · filed 2022-08-11 | $622.00K 10-Q · filed 2022-08-11 | $913.00K derived: sum of 3 quarters · filed 2022-08-11 | $995.00K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $309.00K 10-Q · filed 2022-05-12 | $600.00K derived: sum of 2 quarters · filed 2022-05-12 | $682.00K derived: sum of 3 quarters · filed 2022-05-12 | $754.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $291.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $373.00K derived: sum of 2 quarters · filed 2022-03-10 | $445.00K derived: sum of 3 quarters · filed 2022-03-10 | $519.00K 10-K · filed 2022-03-10 | $519.38K 10-K · filed 2021-03-11 | |||
| 2020-09-30 | $82.00K 10-Q · filed 2021-11-10 | $82.27K 10-Q · filed 2020-11-05 | $154.00K derived: sum of 2 quarters · filed 2021-11-10 | $228.00K 10-Q · filed 2021-11-10 | $227.78K 10-Q · filed 2020-11-05 | $309.68K derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $72.00K 10-Q · filed 2021-08-11 | $71.88K 10-Q · filed 2020-08-06 | $146.00K 10-Q · filed 2021-08-11 | $145.51K 10-Q · filed 2020-08-06 | $227.68K derived: sum of 3 quarters · filed 2021-08-11 | $291.86K derived: sum of 4 quarters · filed 2021-08-11 | ||
| 2020-03-31 | $74.00K 10-Q · filed 2021-05-11 | $73.63K 10-Q · filed 2020-05-07 | $155.68K derived: sum of 2 quarters · filed 2021-05-11 | $219.86K derived: sum of 3 quarters · filed 2021-05-11 | $288.81K derived: sum of 4 quarters · filed 2021-05-11 | |||
| 2019-12-31 | $81.68K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $145.86K derived: sum of 2 quarters · filed 2021-03-11 | $214.81K derived: sum of 3 quarters · filed 2021-03-11 | $300.23K 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | $64.18K 10-Q · filed 2020-11-05 | $133.14K derived: sum of 2 quarters · filed 2020-11-05 | $218.55K 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | $68.96K 10-Q · filed 2020-08-06 | $154.37K 10-Q · filed 2020-08-06 | ||||||
| 2019-03-31 | $85.42K 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |